Effectiveness of Neuromuscular Kinesiology Taping in Plantar Fasciitis

November 28, 2023 updated by: CARMEN GARCÍA GOMARIZ, University of Valencia

One of the pathologies most studied and treated with kinesiotape (KT) is plantar fasciitis (PF). In most of the studies reviewed, it is concluded that there is an improvement in the symptoms of PF when treated with KT: either combined with other therapies or as a single treatment compared to placebo. However, most current studies have limitations because the sample is small, the effect size is small, and the evidence is insufficient or of low quality.

In the present work, the aim is to study the effectiveness of KT in PF, and to compare the results with those obtained in a placebo group, which is treated with tape. The researchers will assess the decrease in symptoms prior to performing other definitive treatments. In addition, the variability of the painful symptoms and the durability of the bandage will be studied, in order to determine whether it can be used in the short or long period of time, being able to take it into account and supposing a supplement to the pharmacological treatment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Valencia
      • València, Valencia, Spain, 46010
        • Universitat de València

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • People with acute plantar fasciitis with less than 3 months of evolution
  • Who present pain in the fascia both during ambulation and on palpation
  • Ecographic image compatible with plantar fasciitis (> 4 mm)
  • The condition has not be previously treated with other treatment

Exclusion Criteria:

  • Condition with no sintomatology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: kinesiotaping
Perform a neuromuscular bandage with kinesiotape in patients with plantar fasciitis
Placebo Comparator: Tape
Perform a neuromuscular bandage with tape (Hipofix(R)) in patients with plantar fasciitis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale of Pain
Time Frame: Change from baseline (before intervention) to one day, two days, three days and four days after intervention
A visual analogue scale of pain will assess from 0, no pain, to 10, the worst possible pain
Change from baseline (before intervention) to one day, two days, three days and four days after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bandage durability
Time Frame: Change from baseline (the bandage is put on) until the first day that the loss of the bandage is documented, assessed up to 7 days
Period of time in days from when the bandage is put on until it comes off
Change from baseline (the bandage is put on) until the first day that the loss of the bandage is documented, assessed up to 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2022

Primary Completion (Actual)

October 29, 2022

Study Completion (Actual)

October 30, 2022

Study Registration Dates

First Submitted

March 22, 2022

First Submitted That Met QC Criteria

April 6, 2022

First Posted (Actual)

April 14, 2022

Study Record Updates

Last Update Posted (Actual)

November 29, 2023

Last Update Submitted That Met QC Criteria

November 28, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • VNM_CC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fasciitis, Plantar

Clinical Trials on Kinesiotaping

Subscribe